Skip to Content

Clinical Trials Details

CALGB 50904

Patient Information

CALGB 50904 - A Randomized Phase II Trial of Ofatumumab and Bendamustine vs. Ofatumumab, Bortezomib, and Bendamustine in Patients with Untreated Follicular Lymphoma

View more information about clinical trial - CALGB 50904

Study Number
CALGB 50904

Clinical Trial Categories

  • Lymphoma


  • Cone Health Cancer Center at Wesley Long
    501 N. Elam Avenue
    Greensboro, NC 27403
    Main: 336-832-1100

Also in this Section